Cholesteatoma and family history: An international survey.


Journal

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
ISSN: 1749-4486
Titre abrégé: Clin Otolaryngol
Pays: England
ID NLM: 101247023

Informations de publication

Date de publication:
07 2020
Historique:
received: 12 11 2019
revised: 15 02 2020
accepted: 08 03 2020
pubmed: 10 4 2020
medline: 24 8 2021
entrez: 10 4 2020
Statut: ppublish

Résumé

To explore the relative frequency of a family history of cholesteatoma in patients with known cholesteatoma, and whether bilateral disease or earlier diagnosis is more likely in those with a family history. Associations between cleft lip or palate and bilateral disease and age of diagnosis were also explored. An online survey of patients with diagnosed cholesteatoma was conducted between October 2017 and April 2019. The sample consisted of patients recruited from two UK clinics and self-selected respondents recruited internationally via social media. Side of cholesteatoma, whether respondents had any family history of cholesteatoma, age of diagnosis and personal or family history of cleft lip or palate were recorded. Of 857 respondents, 89 (10.4%) reported a positive family history of cholesteatoma. Respondents with a family history of cholesteatoma were more likely to have bilateral cholesteatoma (P = .001, odds ratio (OR) 2.15, 95% confidence interval (CI) 1.35-3.43), but there was no difference in the age of diagnosis (P = .23). Those with a history of cleft lip or palate were not more likely to have bilateral disease (P = .051, OR 2.71, CI 1.00-7.38), and there was no difference in age of diagnosis (P = .11). The relatively high proportion of respondents that reported a family history of cholesteatoma offers supporting evidence of heritability in cholesteatoma. The use of social media to recruit respondents to this survey means that the results cannot be generalised to other populations with cholesteatoma. Further population-based research is suggested to determine the heritability of cholesteatoma.

Identifiants

pubmed: 32271986
doi: 10.1111/coa.13544
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

500-505

Informations de copyright

© 2020 The Authors. Clinical Otolaryngology published by John Wiley & Sons Ltd.

Références

Kemppainen HO, Puhakka HJ, Laippala PJ, Sipilä MM, Manninen MP, Karma PH. Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol. 1999;119(5):568-572.
Rosenfeld RM, Moura RL, Bluestone CD. Predictors of residual-recurrent cholesteatoma in children. JAMA Otolaryngol-Head Neck Surg. 1992;118(4):384-391.
Djurhuus BD, Faber CE, Skytthe A. Decreasing incidence rate for surgically treated middle ear cholesteatoma in Denmark 1977-2007. Dan Med Bull. 2010;57(10):A4186.
Bhutta MF, Williamson IG, Sudhoff HH. Cholesteatoma. BMJ. 2011;342:d1088.
Jennings BA, Prinsley P, Philpott C, Willis G, Bhutta MF. The genetics of cholesteatoma. A systematic review using narrative synthesis. Clin Otolaryngol. 2018;43(1):55-67.
Prinsley P, Jennings BA, Bhutta M, Swan D, Willis G, Philpott C. The genetics of cholesteatoma study. Loss-of-function variants in an affected family. Clin Otolaryngol. 2019;44(5):826-830.
Djurhuus BD, Skytthe A, Faber CE, Christensen K. Cholesteatoma risk in 8,593 orofacial cleft cases and 6,989 siblings: a nationwide study. Laryngoscope. 2015;125(5):1225-1229.
Harris L, Cushing SL, Hubbard B, Fisher D, Papsin BC, James AL. Impact of cleft palate type on the incidence of acquired cholesteatoma. Int J Pediatr Otorhinolaryngol. 2013;77(5):695-698.
Bergamaschi R, Bergonzoni C, Mazzanti L, et al. Hearing loss in turner syndrome: results of a multicentric study. J Endocrinol Invest. 2008;31(9):779-783.
Lim D, Gault EJ, Kubba H, Morrissey M, Wynne DM, Donaldson M. Cholesteatoma has a high prevalence in Turner syndrome, highlighting the need for earlier diagnosis and the potential benefits of otoscopy training for paediatricians. Acta Paediatr. 2014;103(7):e282-e287.
Olszewska E, Wagner M, Bernal-Sprekelsen M, et al. Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol. 2004;261(1):6-24.
Mossey PA, Little J, Munger RG, Dixon MJ, Shaw WC. Cleft lip and palate. Lancet. 2009;374(9703):1773-1785.

Auteurs

Rachael Collins (R)

Norwich Medical School, University of East Anglia, Norwich, UK.
ENT Department, Norfolk and Norwich University Hospital, Norwich, UK.

Ngan Hong Ta (NH)

Norwich Medical School, University of East Anglia, Norwich, UK.

Barbara A Jennings (BA)

Norwich Medical School, University of East Anglia, Norwich, UK.

Peter Prinsley (P)

Norwich Medical School, University of East Anglia, Norwich, UK.
ENT Department, James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK.

Carl M Philpott (CM)

ENT Department, James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK.

Nick Steel (N)

Norwich Medical School, University of East Anglia, Norwich, UK.

Allan Clark (A)

Norwich Medical School, University of East Anglia, Norwich, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH